SCHEMBL6707977

SCHEMBL6707977

COCCOc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)n(C)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.37
GRM4 Q14833 1/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
F10 P00742 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MALT1 Q9UDY8 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
BRPF1 P55201 1/20 0.34
ROCK1 Q13464 1/20 0.34
SGMS2 Q8NHU3 1/20 0.33
LCK P06239 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711705 0.92 MAPT (0.36) IRAK4GRM4LMNAMAPTRXFP1
SCHEMBL6710193 0.91 PPARG (0.36) GRM4LMNAMAPTRXFP1ROCK1
SCHEMBL6709977 0.91 GRM4 (0.36) IRAK4GRM4LMNAMAPTRXFP1
SCHEMBL6712280 0.90 NPSR1 (0.36) LMNAMAPTRXFP1MALT1KDM4E
SCHEMBL6711771 0.89 RXFP1 (0.33) GRM4LMNAMAPTRXFP1ROCK1
SCHEMBL6707711 0.89 MAPT (0.39) GRM4LMNAMAPTALDH1A1HPGD
SCHEMBL6710394 0.88 KDM1A (0.37) GRM4LMNAMAPT
SCHEMBL6708936 0.88 KDM1A (0.34) LMNAMAPTRXFP1BRPF1LCK
SCHEMBL6710050 0.88 TSHR (0.38) GRM4LMNAMAPTRXFP1KDM4E
SCHEMBL6710121 0.88 IRAK4 (0.39) IRAK4GRM4LMNAMAPTF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 IRAK4 1592/4885GRM4 4668/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.